ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,112.96
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) News

Vor Biopharma (VOR)

Vor Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VOR
DateTimeSourceHeadlineSymbolCompany
09/05/202421:05GlobeNewswire Inc.Vor Bio Reports First Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
09/05/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
07/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
07/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
06/05/202413:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
03/05/202421:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
02/05/202421:01GlobeNewswire Inc.Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of DirectorsNASDAQ:VORVor Biopharma Inc
01/04/202413:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
20/03/202420:05GlobeNewswire Inc.Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
05/03/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/03/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/03/202421:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
04/03/202413:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
14/02/202421:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VORVor Biopharma Inc
08/02/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/02/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
07/02/202413:00GlobeNewswire Inc.Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VORVor Biopharma Inc
02/02/202421:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
01/02/202400:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
01/02/202400:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
17/01/202421:01GlobeNewswire Inc.Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate UpdateNASDAQ:VORVor Biopharma Inc
05/01/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
21/12/202321:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
01/12/202321:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
27/11/202313:00GlobeNewswire Inc.Vor Bio to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:VORVor Biopharma Inc
09/11/202321:01GlobeNewswire Inc.Vor Bio Presents Positive Data Update on Trem-cel at HSCT² ConferenceNASDAQ:VORVor Biopharma Inc
08/11/202321:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/11/202321:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
07/11/202321:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
07/11/202321:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:VOR

Your Recent History

LSE
NG.
National Grid
LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
CHLL
Chill Brands
LSE
POS
Plexus
LSE
CUSN
Cornish Metals
LSE
OPTI
Optibiotix Health
LSE
BARC
Barclays
LSE
FDEV
Frontier Developments
LSE
IQE
Iqe
LSE
BOO
Boohoo
LSE
GDR
Genedrive
LSE
GOLD
LSE
HUM
Hummingbird Resources
LSE
TEK
Tekcapital
LSE
AVCT
Avacta
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved